---
title: "DarioHealth adds new Blue Cross Blue Shield to payer network"
date: "2025-02-07 16:38:47"
summary: "DarioHealth (NASDAQ:DRIO) taps into the $1.2T cardiometabolic market with new Blue Cross Blue Shield Agreement, which will utilize its AI-driven digital health platform which has shown a 58% reduction in hyperglycemic events, and 59% drop in anxiety symptoms. Recently, it also reported strong revenue growth, operational cash flow positivity targeted..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* DarioHealth (NASDAQ:[DRIO](https://seekingalpha.com/symbol/DRIO "DarioHealth Corp.")) taps into the $1.2T cardiometabolic market with new Blue Cross Blue Shield Agreement, which will utilize its AI-driven digital health platform which has shown a 58% reduction in hyperglycemic events, and 59% drop in anxiety symptoms.
* Recently, it also reported strong revenue growth, operational cash flow positivity targeted by [mid-2025](https://seekingalpha.com/pr/19995513-market-news-alert-dariohealth-secures-significant-new-agreement-expanding-growth-in-the-1_2), $40.6M cash position, and strategic collaborations position Dario as a potential Digital Health Powerhouse.
* According to the Co., the BCBS partnership, launched in January 2025, is already contributing to Dario's recurring revenue growth and is expected to expand throughout the year.
* Multiple Wall Street analysts have reportedly rated Dario a strong buy.
* DRIO +9.9% premarket to $0.7351.

[seekalpha](https://seekingalpha.com/news/4405126-dariohealth-adds-new-blue-cross-blue-shield-to-payer-network)
